Contracts for NeuroLogica, Philips, Thomson Healthcare

NeuroLogica Corporation’s CereTom has been installed at the Methodist Hospital in Indianapolis, Ind. The CereTom a portable and wireless head and neck mobile CT scanner that the facility hopes will add new dimension of accessibility for its patients who will benefit from its mobility, which during the first twenty-one working days since being implemented was used for over 90 bedside CT scans. In addition to bedside scans, the CereTom can be used in the intensive care unit, operating room, and emergency room.


Royal Philips Electronics announced installations of new cardiac electrophysiology (EP) labs at University of California San Francisco Medical Center and St. Elizabeth’s Hospital, Boston, designed to improve catheter navigation within the heart’s chambers. Pairing the ceiling-mounted Philips Allura Xper FD10 X-ray system together with the Stereotaxis Niobe system using magnetic navigation capabilities, the combined system is designed to provide flexibility and improved catheter stability for physicians during complex interventional cardiovascular procedures. The combination system also enables operators to treat complex lesions with greater confidence and is expected to speed up procedures through accurate and reproducible navigation of catheters and guide wires to targeted locations.


Thomson Healthcare announced that Hunterdon Medical Center in Flemington, N.J., is implementing its Order Set Solution, an application designed to improve a hospital’s performance management in the medication care delivery and disease management process by providing evidence-based recommendations.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.